Bilastine is a second-generation, non-sedating H1 antihistamine used for allergic rhinitis and chronic urticaria, with minimal CNS penetration and no significant cardiac liability. Simson Pharma's Bilastine reference standard and impurities support stability-indicating testing for this favourable-profile antihistamine.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Bilastine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.